WS #16822

The dominant market-moving event is the Democratic sweep of the US Congress, confirmed by victories in the House, Senate, and key states like Texas and Kansas. This 'blue wave' has triggered a repricing of the political risk premium: the dollar weakened, European equities and Asian markets rallied, and the market is pricing in a shift toward regulatory scrutiny for Big Tech and AI, alongside potential fiscal stimulus. Trump's concession and attribution of the loss to the Iran war (linked to the ongoing Middle East escalation) signal a potential de-escalation of geopolitical tensions, which is supporting risk assets and energy stocks. In the technology sector, AMD delivered a massive beat with Q3 data center revenue surging 97% YoY, reinforcing the AI infrastructure thesis despite the political headwinds. Conversely, Apple faces a dual threat: a significant patent ruling in the US that could result in record billions in damages, and a regulatory ban in Brazil preventing Meta from using press content for AI training, highlighting the intensifying global regulatory risk for tech giants. Meta is simultaneously executing a massive $15 billion debt issuance, signaling strong balance sheet confidence despite the regulatory noise. In healthcare, Novo Nordisk raised its full-year outlook driven by sustained demand for GLP-1 drugs (Wegovy/Ozempic), providing a bullish counter-narrative to the broader tech volatility. Meanwhile, the energy sector is seeing mixed signals: BP is restructuring its downstream leadership, while Europa Oil & Gas sees insider buying, but the broader macro backdrop of a stronger Democratic Congress may temper energy subsidies previously promised by Republicans.